← k3vl4r
Log inGet started →

NRXP Price Forecast

AI-generated price forecast for NRXP across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

As of July 2026: K3vl4r's AI model currently reads NRXP as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 4.33. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status

Last price

4.33

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏 Post✈ Telegram

NRXP forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour~3 weeks out———
4-hour~3 months out———
Daily~6 months out▼ Down-43.87%—
Weekly~2 years out▼ Down-100.00%—

Latest NRXP news

From the market-news feed the forecasts are read against.

  • Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation? · Insider Monkey · Jul 15
  • NRx Pharmaceuticals Issues Statement In Response To Kadima Allegations, Citing Arbitration Over Non‑Acquisition By HOPE Therapeutics · Benzinga · Jun 25
  • NRx Pharma’s HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System · Benzinga · Jun 25
  • NRx Pharma Announces FDA Approval Of Intermediate Population Expanded Access Protocol For Use Of NRX-101, Fixed Dose Combination Of DCS And Lurasidone For Augmentation Of Accelerated TMS · Benzinga · Jun 22
  • NRX Pharmaceuticals Inc (NRXP) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... · GuruFocus.com · Jun 17

🔒

See the full NRXP forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

NRXP forecast — frequently asked

Will NRXP go up?

K3vl4r's AI model currently reads NRXP as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the NRXP price prediction for 2026?

K3vl4r's model projects NRXP toward $4.22 over the next ~6 months, a -0.4% move from $4.24. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could NRXP reach?

Over its longest horizon (~~2 years), the model's projected target for NRXP is $4.20 (-1.0% vs $4.24). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

SVRAGEHCBOLDPLRXHQYCNTNCLYMTVRDHOWLQUREAVNSLUCYATAICRNX

Will NRXP reach…?

Will NRXP reach $5.00?Will NRXP reach $10.00?Will NRXP reach $20.00?Will NRXP reach $25.00?

Or see the full NRXP price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare NRXP

NRXP vs SVRANRXP vs GEHCNRXP vs BOLDNRXP vs PLRXNRXP vs HQYNRXP vs CNTN

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

k3vl4rTop PicksTrack recordChart indicatorsToday's outlookBiggest moversMarket heatmapForecasts by sectorAI reportsCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)Twitch — live forecastingDiscord community

Join the community on Discord and catch live forecasting on Twitch. Create a free account →

Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Status.